4//SEC Filing
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 4
Accession 0000950170-22-025513
CIK 0001781174other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 1:22 PM ET
Size
7.1 KB
Accession
0000950170-22-025513
Insider Transaction Report
Form 4
Transactions
- Conversion
Common Stock
2022-11-17+888,130→ 888,130 total - Conversion
Series B Preferred Stock
2022-11-17−2,190,131→ 0 total→ Common Stock (888,130 underlying)
Footnotes (1)
- [F1]On November 17, 2022, the Series B Preferred Stock automatically converted into Common Stock on a 1-to-2.466 basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock had no expiration date.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001787092
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 1:22 PM ET
- Size
- 7.1 KB